Remove 2014 Remove Clinical Trials Remove Conditions Remove Patients
article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

article thumbnail

Press Release: MAPS Places Fully Validated, Multi-Kilogram Synthesis of MDMA in the Public Domain?

Cannabis Law Report

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Best strains and terpenes for pain management

The Cannigma

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. One of the major reasons cannabis grew so popular with medical marijuana patients is its perceived ability to manage pain, particularly pain that other medications can’t help. And this is an area of ample scientific research.

Terpenes 111
article thumbnail

How medical marijuana could help you find the ‘new you’ in the New Year

Canna Care Docs

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms.

article thumbnail

A Patient’s Guide to CBD and Drug Interactions

Healer

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD 98
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105
article thumbnail

Announcement: Michael Mullette Joins MAPS PBC Senior Leadership as Chief Operating Officer

Cannabis Law Report

Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA. I’m thrilled to expand our team with another experienced partner who shares our values. Amy Emerson , CEO, MAPS PBC.

Therapy 52